
Lital Keinan
Featured in:
biomedcentral.com
Articles
-
Apr 23, 2024 |
ijhpr.biomedcentral.com | Tel Hashomer |Ramat Gan |Sackler Faculty |Lital Keinan
The current SCCS study, based on Israel national databases, examined whether risk for acute cardiovascular events (excluding myocarditis) and mortality within 30 days of administration of the 2nd Pfizer vaccine dose against COVID19, was higher than the risk during the next 30 days. The results indicated that there were no substantial differences with respect to acute cardiovascular events (excluding myocarditis), even after accounting for potential moderators.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →